INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,416 | +67.6% | 400 | 0.0% | 0.00% | – |
Q2 2023 | $4,424 | -17.6% | 400 | 0.0% | 0.00% | – |
Q1 2023 | $5,372 | +8.6% | 400 | 0.0% | 0.00% | – |
Q4 2022 | $4,948 | -1.0% | 400 | 0.0% | 0.00% | – |
Q3 2022 | $5,000 | 0.0% | 400 | 0.0% | 0.00% | – |
Q2 2022 | $5,000 | -16.7% | 400 | 0.0% | 0.00% | – |
Q1 2022 | $6,000 | 0.0% | 400 | 0.0% | 0.00% | – |
Q4 2021 | $6,000 | 0.0% | 400 | 0.0% | 0.00% | – |
Q3 2021 | $6,000 | -14.3% | 400 | 0.0% | 0.00% | – |
Q2 2021 | $7,000 | 0.0% | 400 | 0.0% | 0.00% | – |
Q1 2021 | $7,000 | -22.2% | 400 | 0.0% | 0.00% | – |
Q4 2020 | $9,000 | -43.8% | 400 | 0.0% | 0.00% | -100.0% |
Q3 2020 | $16,000 | -46.7% | 400 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $30,000 | +15.4% | 400 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $26,000 | -46.9% | 400 | 0.0% | 0.00% | -33.3% |
Q4 2019 | $49,000 | +96.0% | 400 | 0.0% | 0.00% | +200.0% |
Q3 2019 | $25,000 | -19.4% | 400 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $31,000 | -29.5% | 400 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $44,000 | -21.4% | 400 | -33.3% | 0.00% | -25.0% |
Q4 2018 | $56,000 | -11.1% | 600 | +20.0% | 0.00% | 0.0% |
Q3 2018 | $63,000 | +90.9% | 500 | +25.0% | 0.00% | +33.3% |
Q2 2018 | $33,000 | +37.5% | 400 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $24,000 | +4.3% | 400 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $23,000 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $23,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |